rs1057519703
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Transcriptome sequencing of melanocytic nevi and melanomas from Grm1 transgenic mice to determine melanoma driver mutations.
|
24661573 |
2014 |
rs1057519703
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
The GIST of targeted therapy for malignant melanoma.
|
24531699 |
2014 |
rs1057519703
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
Transcriptome sequencing of melanocytic nevi and melanomas from Grm1 transgenic mice to determine melanoma driver mutations.
|
24661573 |
2014 |
rs1057519704
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Activating c-KIT mutations in a subset of thymic carcinoma and response to different c-KIT inhibitors.
|
22357254 |
2012 |
rs1057519704
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Impressive response with imatinib in a heavily pretreated patient with metastatic c-KIT mutated thymic carcinoma.
|
21969494 |
2011 |
rs1057519705
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
Transcriptome sequencing of melanocytic nevi and melanomas from Grm1 transgenic mice to determine melanoma driver mutations.
|
24661573 |
2014 |
rs1057519705
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
The GIST of targeted therapy for malignant melanoma.
|
24531699 |
2014 |
rs1057519706
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
Transcriptome sequencing of melanocytic nevi and melanomas from Grm1 transgenic mice to determine melanoma driver mutations.
|
24661573 |
2014 |
rs1057519706
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
The GIST of targeted therapy for malignant melanoma.
|
24531699 |
2014 |
rs1057519708
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
The GIST of targeted therapy for malignant melanoma.
|
24531699 |
2014 |
rs1057519708
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Transcriptome sequencing of melanocytic nevi and melanomas from Grm1 transgenic mice to determine melanoma driver mutations.
|
24661573 |
2014 |
rs1057519708
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
KIT amplification and gene mutations in acral/mucosal melanoma in Korea.
|
21569090 |
2011 |
rs1057519713
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Secondary c-Kit mutations confer acquired resistance to RTK inhibitors in c-Kit mutant melanoma cells.
|
23582185 |
2013 |
rs121913235
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Constitutively activating mutations of c-kit receptor tyrosine kinase confer factor-independent growth and tumorigenicity of factor-dependent hematopoietic cell lines.
|
7530509 |
1995 |
rs121913235
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Gain-of-function mutation at the extracellular domain of KIT in gastrointestinal stromal tumours.
|
11276010 |
2001 |
rs121913235
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Phase II, open-label, single-arm trial of imatinib mesylate in patients with metastatic melanoma harboring c-Kit mutation or amplification.
|
21690468 |
2011 |
rs121913235
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Activity of dasatinib against L576P KIT mutant melanoma: molecular, cellular, and clinical correlates.
|
19671763 |
2009 |
rs121913235
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Sunitinib therapy for melanoma patients with KIT mutations.
|
22261812 |
2012 |
rs121913235
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Major response to imatinib mesylate in KIT-mutated melanoma.
|
18421059 |
2008 |
rs121913235
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
KIT gene mutations and copy number in melanoma subtypes.
|
18980976 |
2008 |
rs121913235
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Response to imatinib mesylate depends on the presence of the V559A-mutated KIT oncogene.
|
19812602 |
2010 |
rs121913235
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
L576P KIT mutation in anal melanomas correlates with KIT protein expression and is sensitive to specific kinase inhibition.
|
17372901 |
2007 |
rs121913235
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
KIT as a therapeutic target in metastatic melanoma.
|
21642685 |
2011 |
rs121913235
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Sunitinib therapy for melanoma patients with KIT mutations.
|
22261812 |
2012 |
rs121913235
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Complete response of stage IV anal mucosal melanoma expressing KIT Val560Asp to the multikinase inhibitor sorafenib.
|
18936790 |
2008 |